Literature DB >> 28131385

Comparison of three feline leukaemia virus (FeLV) point-of-care antigen test kits using blood and saliva.

Mark E Westman1, Richard Malik2, Evelyn Hall3, Paul A Sheehy3, Jacqueline M Norris4.   

Abstract

Feline leukaemia virus (FeLV) can be a challenging infection to diagnose due to a complex feline host-pathogen relationship and occasionally unreliable test results. This study compared the accuracy of three point-of-care (PoC) FeLV p27 antigen test kits commonly used in Australia and available commercially worldwide (SNAP FIV/FeLV Combo, Witness FeLV/FIV and Anigen Rapid FIV/FeLV), using detection of FeLV provirus by an in-house real-time polymerase chain reaction (qPCR) assay as the diagnostic gold standard. Blood (n=563) and saliva (n=419) specimens were collected from a population of cats determined to include 491 FeLV-uninfected and 72 FeLV-infected individuals (45 progressive infections [p27 and qPCR positive], 27 regressive infections [p27 negative, qPCR positive]). Sensitivity and specificity using whole blood was 63% and 94% for SNAP Combo, 57% and 98% for Witness, and 57% and 98% for Anigen Rapid, respectively. SNAP Combo had a significantly lower specificity using blood compared to the other two kits (P=0.004 compared to Witness, P=0.007 compared to Anigen Rapid). False-positive test results occurred with all three kits using blood, and although using any two kits in parallel increased specificity, no combination of kits completely eliminated the occurrence of false-positive results. We therefore recommend FeLV proviral PCR testing for any cat that tests positive with a PoC FeLV antigen kit, as well as for any cat that has been potentially exposed to FeLV but tests negative with a FeLV antigen kit, before final assignment of FeLV status can be made with confidence. For saliva testing, sensitivity and specificity was 54% and 100%, respectively, for all three test kits. The reduced sensitivity of saliva testing compared to blood testing, although not statistically significant, suggests saliva testing with the current generation of PoC FeLV antigen kits is unsuitable for screening large populations of cats, such as in shelters.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antigen testing; Cats; FeLV diagnosis; Feline leukaemia virus; PCR; Saliva; Whole blood

Mesh:

Substances:

Year:  2016        PMID: 28131385     DOI: 10.1016/j.cimid.2016.11.014

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  9 in total

1.  Molecular Detection of Feline Leukemia Virus in Oral, Conjunctival, and Rectal Mucosae Provides Results Comparable to Detection in Blood.

Authors:  Raphael Mattoso Victor; Juliana Marques Bicalho; Manuela Bamberg Andrade; Bruna Lopes Bueno; Luiza Rodrigues Alves de Abreu; Adriane Pimenta da Costa Val Bicalho; Jenner Karlisson Pimenta Dos Reis
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

2.  Diagnostic performances of two rapid tests for detection of feline leukemia virus antigen in sera of experimentally feline leukemia virus-infected cats.

Authors:  Matthew R Krecic; Sridhar Velineni; Patrick Meeus; Huihao Fan; Michael Loenser
Journal:  JFMS Open Rep       Date:  2018-01-02

3.  Prevalence and risk factor analysis for feline haemoplasmas in cats from Northern Serbia, with molecular subtyping of feline immunodeficiency virus.

Authors:  Elpida Sarvani; Séverine Tasker; Milica Kovacˇević Filipović; Jelena Francuski Andrić; Nenad Andrić; Larissa Aquino; Sarah English; Charalampos Attipa; Christian M Leutenegger; Chris R Helps; Kostas Papasouliotis
Journal:  JFMS Open Rep       Date:  2018-05-22

4.  The Diagnosis of Feline Leukaemia Virus (FeLV) Infection in Owned and Group-Housed Rescue Cats in Australia.

Authors:  Mark Westman; Jacqueline Norris; Richard Malik; Regina Hofmann-Lehmann; Andrea Harvey; Alicia McLuckie; Martine Perkins; Donna Schofield; Alan Marcus; Mike McDonald; Michael Ward; Evelyn Hall; Paul Sheehy; Margaret Hosie
Journal:  Viruses       Date:  2019-05-31       Impact factor: 5.048

Review 5.  Interferon-omega: Current status in clinical applications.

Authors:  Shi-Fang Li; Fu-Rong Zhao; Jun-Jun Shao; Yin-Li Xie; Hui-Yun Chang; Yong-Guang Zhang
Journal:  Int Immunopharmacol       Date:  2017-10-12       Impact factor: 4.932

6.  Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax® Lv-K and Fel-O-Vax® 5).

Authors:  Mark Westman; Jacqueline Norris; Richard Malik; Regina Hofmann-Lehmann; Yasmin A Parr; Emma Armstrong; Mike McDonald; Evelyn Hall; Paul Sheehy; Margaret J Hosie
Journal:  Viruses       Date:  2021-02-03       Impact factor: 5.048

7.  Feline Leukemia Virus p27 Antigen Concentration and Proviral DNA Load Are Associated with Survival in Naturally Infected Cats.

Authors:  Melissa J Beall; Jesse Buch; Genevieve Clark; Marko Estrada; Andrei Rakitin; Natascha T Hamman; Monica K Frenden; Ellen P Jefferson; E Susan Amirian; Julie K Levy
Journal:  Viruses       Date:  2021-02-15       Impact factor: 5.048

8.  Rapid characterization of feline leukemia virus infective stages by a novel nested recombinase polymerase amplification (RPA) and reverse transcriptase-RPA.

Authors:  Sitthichok Lacharoje; Somporn Techangamsuwan; Nuntaree Chaichanawongsaroj
Journal:  Sci Rep       Date:  2021-11-11       Impact factor: 4.379

9.  Felis Catus Gammaherpesvirus 1 DNAemia in Whole Blood from Therapeutically Immunosuppressed or Retrovirus-Infected Cats.

Authors:  Alicia J McLuckie; Vanessa R Barrs; Bethany Wilson; Mark E Westman; Julia A Beatty
Journal:  Vet Sci       Date:  2017-03-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.